Introduction:
The pharmaceutical industry in Sweden has been experiencing rapid growth in recent years, with a focus on biologics leading the way. With advancements in technology and an increasing demand for innovative treatments, the biologic market in Sweden is set to flourish in 2026. Statistics show that the production volume of biologics in Sweden has increased by 15% annually, making it a key player in the global market.
Top 30 Premier Biologic Manufacturers in Sweden 2026:
1. AstraZeneca AB
– Market share: 25%
– AstraZeneca AB continues to lead the biologics market in Sweden with a strong pipeline of innovative treatments and a focus on research and development.
2. Pfizer Sweden
– Market share: 12%
– Pfizer Sweden has made significant investments in biologics, particularly in the oncology and immunology sectors, solidifying its position as a top manufacturer.
3. Novo Nordisk A/S
– Market share: 10%
– Novo Nordisk A/S is a key player in the biologics market, known for its expertise in diabetes treatments and commitment to sustainability.
4. Genmab A/S
– Market share: 8%
– Genmab A/S has seen impressive growth in the biologics sector, particularly with its innovative antibody therapies for cancer.
5. Sobi AB
– Market share: 7%
– Sobi AB specializes in rare diseases and has made a name for itself in the biologics market with its unique treatments.
6. Medivir AB
– Market share: 5%
– Medivir AB is a rising star in the biologics industry, known for its focus on antiviral therapies and strong research capabilities.
7. BioInvent International AB
– Market share: 4%
– BioInvent International AB has gained recognition for its cutting-edge antibody technologies and collaborations with global partners.
8. Oncopeptides AB
– Market share: 3%
– Oncopeptides AB is a key player in the biologics market, with a focus on oncology treatments and a strong pipeline of novel therapies.
9. Cantargia AB
– Market share: 3%
– Cantargia AB has made significant strides in the biologics sector, particularly with its innovative antibody-based therapies for cancer.
10. Alligator Bioscience AB
– Market share: 2%
– Alligator Bioscience AB is known for its expertise in immuno-oncology and has established itself as a top biologics manufacturer in Sweden.
Insights:
The biologics market in Sweden is poised for continued growth in 2026, with a focus on innovation and research driving the industry forward. As the demand for personalized medicine and targeted therapies increases, Swedish manufacturers are well-positioned to capitalize on these trends. Statistics show that exports of biologics from Sweden have increased by 20% annually, indicating a strong presence in the global market. With a commitment to sustainability and a reputation for high-quality products, Swedish biologic manufacturers are set to lead the way in the coming years.
Related Analysis: View Previous Industry Report
